...
【24h】

Positive control in a 'thorough QT/QTc study'

机译:“全面的QT / QTc研究”中的阳性对照

获取原文
获取原文并翻译 | 示例
           

摘要

In a recent issue of the Journal of Clinical Pharmacology, Chatterjee et al1 reported the first "thorough QT/QTc study" on GLP-1 analog liraglu-tide. Although the study provided important scientific information on the effects of liraglutide on the QT/QTc intervals, treatment of the positive control deserves additional discussion.In this study, the authors claimed that the upper bound of the 95% one-sided confidence intervals for the maximum mean difference of time-matched, baseline-subtracted QTc values between the positive control moxifloxacin and placebo, which was larger than 10 ms, confirmed the internal validity of the study to detect prolongation of the QTc interval.
机译:在最近一期的《临床药理学杂志》上,Chatterjee等人1报道了有关GLP-1类似物liraglu-tide的第一个“全面QT / QTc研究”。尽管该研究提供了有关利拉鲁肽对QT / QTc间隔的影响的重要科学信息,但阳性对照的治疗值得进一步讨论。在本研究中,作者声称95%单侧置信区间的上限阳性对照莫西沙星与安慰剂之间时间匹配的,减去基线的QTc值的最大平均差大于10 ms,这证实了该研究检测QTc间隔延长的内部有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号